NCT07481058 2026-03-18
A Study of KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy as First-line Treatment in Patients With Advanced Esophageal Cancer
Beijing Konruns Pharmaceutical Co., Ltd.
Phase 2 Recruiting
Beijing Konruns Pharmaceutical Co., Ltd.
STORM Therapeutics LTD
Coherus Oncology, Inc.
Coherus Oncology, Inc.